We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-8.32%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.29B
AUM Growth
-$303M
Cap. Flow
+$76.4M
Cap. Flow %
2.32%
Top 10 Hldgs %
14.37%
Holding
1,576
New
105
Increased
568
Reduced
547
Closed
231

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$15.9M
2
KMX icon
CarMax
KMX
+$10.9M
3
NFLX icon
Netflix
NFLX
+$7.39M
4
UAL icon
United Airlines
UAL
+$6.3M
5
AMZN icon
Amazon
AMZN
+$5.34M

Top Sells

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$6.94M
2
QCOM icon
Qualcomm
QCOM
+$6.76M
3
BHC icon
Bausch Health
BHC
+$5.37M
4
KMI icon
Kinder Morgan
KMI
+$5.15M
5
PLL
PALL CORP
PLL
+$5.04M

Sector Composition

Rank Sector Weight
1 Healthcare 15.4%
2 Financials 10.61%
3 Consumer Discretionary 9.72%
4 Industrials 9.63%
5 Technology 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AU icon
1276
AngloGold Ashanti
AU
$40.1B
$82K ﹤0.01%
10,000
-3,000
-23% -$22.2K
LINE
1277
DELISTED
LINN ENERGY LLC COM UTS REP LTD LIABILITY CO INTS
LINE
$81K ﹤0.01%
29,966
-4,531
-13% -$20.1K
SPPI
1278
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$80K ﹤0.01%
+13,455
New +$93.4K
BDJ icon
1279
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.73B
$79K ﹤0.01%
+10,988
New +$84.1K
PHK
1280
PIMCO High Income Fund
PHK
$867M
$79K ﹤0.01%
10,607
+34
+0.3% +$308
UTIW
1281
DELISTED
UTI WORLDWIDE INC
UTIW
$79K ﹤0.01%
+17,300
New +$129K
AG icon
1282
First Majestic Silver
AG
$7.41B
$78K ﹤0.01%
24,467
OCSL icon
1283
Oaktree Specialty Lending
OCSL
$1.02B
$78K ﹤0.01%
4,233
TSI
1284
TCW Strategic Income Fund
TSI
$214M
$78K ﹤0.01%
15,000
C.WS.A
1285
DELISTED
Citigroup Inc
C.WS.A
$78K ﹤0.01%
169,000
PTX
1286
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$76K ﹤0.01%
2,385
+350
+17% +$16.7K
IRR
1287
DELISTED
VOYA NATURAL RESOURCES EQUITY INCOME FUND
IRR
$76K ﹤0.01%
12,552
+2,552
+26% +$16.8K
CORT icon
1288
Corcept Therapeutics
CORT
$12.4B
$75K ﹤0.01%
+20,000
New +$101K
AMKR icon
1289
Amkor Technology
AMKR
$12.4B
$74K ﹤0.01%
16,500
-14,500
-47% -$71.3K
NUWE icon
1290
Nuwellis
NUWE
$160K
0
SVBI
1291
DELISTED
Severn Bancorp Inc/MD
SVBI
$70K ﹤0.01%
15,000
GNCA
1292
DELISTED
Genocea Biosciences, Inc.
GNCA
$69K ﹤0.01%
+1,250
New +$124K
BB icon
1293
BlackBerry
BB
$4.98B
$67K ﹤0.01%
11,000
AWP
1294
abrdn Global Premier Properties Fund
AWP
$372M
$63K ﹤0.01%
3,768
+13
+0.3% +$238
ALLT icon
1295
Allot
ALLT
$372M
$62K ﹤0.01%
12,600
-14,940
-54% -$78.7K
PKD
1296
DELISTED
Parker Drilling Company
PKD
$62K ﹤0.01%
1,580
-133
-8% -$5.62K
AMPE
1297
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$58K ﹤0.01%
67
+34
+103% +$28.4K
ANGI icon
1298
Angi Inc
ANGI
$229M
$57K ﹤0.01%
+1,132
New +$57.7K
EPM icon
1299
Evolution Petroleum
EPM
$132M
$56K ﹤0.01%
10,000
KMI.WS
1300
DELISTED
Kinder Morgan Inc
KMI.WS
$55K ﹤0.01%
59,868
-873
-1% -$1.34K

Similar funds

Oppenheimer & Co's Q3 2015 Portfolio in Review

As of Q3 2015, Oppenheimer & Co held 1,576 positions worth $3.29B, down 8.4% from $3.59B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2015 filing shows 105 new, 568 increased, 547 reduced and 231 closed positions. Its largest new stake was PayPal: 112,571 shares worth $3.49M. The largest sale was ConocoPhillips, an estimated $6.94M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Oppenheimer & Co's largest Q3 2015 buy was PayPal: 112,571 shares worth $3.49M.
  • Oppenheimer & Co added most to Gilead Sciences in Q3 2015, an estimated $15.9M increase.
  • Oppenheimer & Co's biggest Q3 2015 reduction was ConocoPhillips, cutting an estimated $6.94M.
  • Oppenheimer & Co fully exited PALL CORP in Q3 2015, selling an estimated $5.04M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.29B portfolio in Q3 2015.
  • Oppenheimer & Co opened 105 new positions and closed 231 in Q3 2015.
  • Oppenheimer & Co's portfolio value fell 8.4% quarter-over-quarter to $3.29B.

Based on Oppenheimer & Co's 13F filing for Q3 2015, filed 13 Nov 2015.